CIK 0001699382
- Non-accelerated filer
- Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463218129
- Phone
- +1 609-642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-29 | INTERWEST PARTNERS X LP 10% owner | Conversion · Series A Preferred Stock | −3,488,398 | 0 | ||
| 2020-09-29 | INTERWEST PARTNERS X LP 10% owner | Conversion · Series B Preferred Stock | −1,040,654 | 0 | ||
| 2020-09-29 | INTERWEST PARTNERS X LP 10% owner | Conversion · Series C Preferred Stock | −265,203 | 0 | ||
| 2020-09-29 | Nextech V Oncology S.C.S., SICAV-SIF Former 10% Owner | Conversion | +1,768,023 | 1,768,023 | ||
| 2020-09-29 | Nextech V Oncology S.C.S., SICAV-SIF Former 10% Owner | Conversion | +760,267 | 2,528,290 | ||
| 2020-09-29 | Nextech V Oncology S.C.S., SICAV-SIF Former 10% Owner | Conversion · Series C Preferred Stock | −1,768,023 | 0 | ||
| 2020-09-29 | Nextech V Oncology S.C.S., SICAV-SIF Former 10% Owner | Conversion · Series D Preferred Stock | −760,267 | 0 | ||
| 2020-09-29 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Former 10% Owner | Conversion | +760,267 | 760,267 | ||
| 2020-09-29 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Former 10% Owner | Conversion · Series D Preferred Stock | −760,267 | 0 | ||
| 2020-09-29 | Euclidean Capital LLC Former 10% Owner | Conversion | +693,769 | 693,769 | ||
| 2020-09-29 | Euclidean Capital LLC Former 10% Owner | Conversion | +2,601,637 | 2,601,637 | ||
| 2020-09-29 | Euclidean Capital LLC Former 10% Owner | Conversion | +751,409 | 751,409 | ||
| 2020-09-29 | Euclidean Capital LLC Former 10% Owner | Conversion | +132,601 | 132,601 | ||
| 2020-09-29 | Euclidean Capital LLC Former 10% Owner | Conversion · Series B Preferred Stock | −693,769 | 0 | ||
| 2020-09-29 | Euclidean Capital LLC Former 10% Owner | Conversion · Series B Preferred Stock | −2,601,637 | 0 | ||
| 2020-09-29 | Euclidean Capital LLC Former 10% Owner | Conversion · Series C Preferred Stock | −751,409 | 0 | ||
| 2020-09-29 | Euclidean Capital LLC Former 10% Owner | Conversion · Series C Preferred Stock | −132,601 | 0 | ||
| 2020-09-29 | Boxer Capital, LLC Former 10% Owner | Conversion | +586,099 | 1,536,099 | ||
| 2020-09-29 | Boxer Capital, LLC Former 10% Owner | Conversion | +732,137 | 2,268,236 | ||
| 2020-09-29 | Boxer Capital, LLC Former 10% Owner | Conversion | +32,708 | 32,708 |
Page 20 of 23 · 457 trades